JP2011502998A5 - - Google Patents

Download PDF

Info

Publication number
JP2011502998A5
JP2011502998A5 JP2010532306A JP2010532306A JP2011502998A5 JP 2011502998 A5 JP2011502998 A5 JP 2011502998A5 JP 2010532306 A JP2010532306 A JP 2010532306A JP 2010532306 A JP2010532306 A JP 2010532306A JP 2011502998 A5 JP2011502998 A5 JP 2011502998A5
Authority
JP
Japan
Prior art keywords
unsubstituted
substituted
bicyclo
compound
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010532306A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011502998A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/082140 external-priority patent/WO2009059243A1/en
Publication of JP2011502998A publication Critical patent/JP2011502998A/ja
Publication of JP2011502998A5 publication Critical patent/JP2011502998A5/ja
Pending legal-status Critical Current

Links

JP2010532306A 2007-11-01 2008-10-31 ウイルス感染の治療および予防 Pending JP2011502998A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US98460107P 2007-11-01 2007-11-01
US4966508P 2008-05-01 2008-05-01
PCT/US2008/082140 WO2009059243A1 (en) 2007-11-01 2008-10-31 Treating and preventing viral infections

Publications (2)

Publication Number Publication Date
JP2011502998A JP2011502998A (ja) 2011-01-27
JP2011502998A5 true JP2011502998A5 (cg-RX-API-DMAC7.html) 2011-12-15

Family

ID=40591505

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010532306A Pending JP2011502998A (ja) 2007-11-01 2008-10-31 ウイルス感染の治療および予防

Country Status (5)

Country Link
US (1) US8466177B2 (cg-RX-API-DMAC7.html)
EP (1) EP2217573A4 (cg-RX-API-DMAC7.html)
JP (1) JP2011502998A (cg-RX-API-DMAC7.html)
CN (1) CN101990534A (cg-RX-API-DMAC7.html)
WO (1) WO2009059243A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3494972T (lt) 2010-01-27 2024-03-12 Viiv Healthcare Company Dolutegraviro ir lamivudino kompozicija živ infekcijai gydyti
WO2011160024A2 (en) * 2010-06-17 2011-12-22 Fuzians Biomedicals, Inc. Compounds useful as antiviral agents, compositions, and methods of use
KR101159000B1 (ko) * 2010-06-18 2012-06-21 (주) 에빅스젠 신규한 로다닌 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 aids 예방 또는 치료용 약학 조성물
US20140303074A1 (en) * 2011-12-16 2014-10-09 The J. David Gladstone Institutes Compositions and Methods For Inhibiting Immunodeficiency Virus Transcription
KR101893988B1 (ko) 2018-05-16 2018-08-31 (주)에빅스젠 로다닌 유도체를 함유하는 aids 예방 또는 치료용 약학 조성물
CN108658891B (zh) * 2018-07-03 2020-09-29 河南农业大学 2-硫代噻唑烷-4-酮、衍生物及其制备方法
CN111995622B (zh) * 2020-08-20 2022-04-15 复旦大学 化合物及其用途
WO2025252235A1 (zh) * 2024-06-07 2025-12-11 宜坤行健生物医药(上海)有限公司 一种用于调节β2整联蛋白的化合物及其药物组合物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3345334A (en) * 1967-03-06 1967-10-03 Du Pont Polyureas, poly (diazolidiones), and process for converting polyureas to poly
GB1601310A (en) * 1978-05-23 1981-10-28 Lilly Industries Ltd Aryl hydantoins
NZ248573A (en) * 1992-09-10 1996-02-27 Lilly Co Eli 5-arylmethyl (and methylidene) thiazolidin-4-one derivatives; their preparation and pharmaceutical compositions
DE4331162A1 (de) * 1993-09-14 1995-03-16 Bayer Ag Verfahren zur Herstellung von Cyaninfarbstoffen
US5684024A (en) * 1996-01-25 1997-11-04 Viropharma Incorporated Pyrazole dimers compositions and methods for treating influenza
WO2000010573A1 (en) * 1998-08-21 2000-03-02 Viropharma Incorporated Compounds, compositions and methods for treating or preventing viral infections and associated diseases
US20020064736A1 (en) * 2000-09-27 2002-05-30 Fuji Photo Film Co., Ltd. Dye-forming coupler, silver halide photographic light-sensitive material, and method for producing an azomethine dye
EP1501509A4 (en) 2002-04-30 2009-07-15 Merck & Co Inc ARYL-LINK-ARYL-SUBSTITUTED THIAZOLIDIN-DION- AND OXAZOLIDIN-DION AS SODIUM CHANNEL BLOCKER
AU2003291024A1 (en) * 2002-11-13 2004-06-03 Rigel Pharmaceuticals, Inc. Rhodanine derivatives and pharmaceutical compositions containing them
DE10348023A1 (de) * 2003-10-15 2005-05-19 Imtm Gmbh Neue Alanyl-Aminopeptidasen-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen
WO2005041951A2 (en) 2003-10-28 2005-05-12 Rigel Pharmaceuticals, Inc. Rhodanine derivatives for use as antiviral agents
JP2008543836A (ja) * 2005-06-15 2008-12-04 ニューヨーク ブラッド センター 複素環置換フェニルフランおよび関連化合物を含む抗ウイルス組成物
GB0521373D0 (en) 2005-10-20 2005-11-30 Kudos Pharm Ltd Pthalazinone derivatives

Similar Documents

Publication Publication Date Title
JP2011502998A5 (cg-RX-API-DMAC7.html)
JP7119158B2 (ja) タンパク質調節因子として有用な複素環式アミド
AU2023270335B2 (en) N4-hydroxycytidine and derivatives and anti-viral uses related thereto
US12414961B2 (en) Substituted nucleosides and nucleotides for treating viral infections
CA3082191C (en) N4-hydroxycytidine and derivatives and anti-viral uses related thereto
AU2018344902B2 (en) Modulators of stimulator of interferon genes (STING) useful in treating HIV
CA2903288C (en) N-acyl-n'-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities
US20230303551A1 (en) N-cyclyl-sulfonamides useful for inhibiting raf
CA2972014A1 (en) Fused pyrimidine compounds for the treatment of hiv
JP2017525753A5 (cg-RX-API-DMAC7.html)
WO2017133667A1 (en) Pyrimidine and pyridine derivatives and use in treatment, amelioration or prevention of influenza thereof
JP2016537346A5 (cg-RX-API-DMAC7.html)
US12440494B2 (en) Compounds useful for inhibiting RAF dimers
WO2013173254A1 (en) Bicyclic compounds as kinases inhibitors
WO2017106710A1 (en) Nucleotide and nucleoside therapeutic compositions and uses related thereto
JP2014510147A5 (cg-RX-API-DMAC7.html)
US11192914B2 (en) Alkyne containing nucleotide and nucleoside therapeutic compositions and uses related thereto
WO2009059243A1 (en) Treating and preventing viral infections
JP2017535549A5 (cg-RX-API-DMAC7.html)
CA2857441A1 (en) Carboxamide-substituted heteroaryl-pyrazoles and their use
US10669270B2 (en) Amide-sulfamide derivatives, compositions, and uses related to CXCR4 inhibition
EP4651872A1 (en) Compounds, compositions and methods of use to treat hypoparathyroidism and osteoporosis
AU2024267852A1 (en) 4'-halogen containing nucleotide and nucleoside therapeutic compositions and uses related thereto
HK40075390A (en) Nucleotide and nucleoside therapeutic compositions and uses related thereto